MAPK1 and pancreatic neoplasm: Additionally, the inhibition of ERK has been observed to promote the activation of AMPK and beclin-1, while reducing mTORC1 signaling and consequently impacting the transcription of genes associated with autophagy in pancreatic cancer [163].